In The News Posted March 5, 2019 Share Posted March 5, 2019 With a new strategic plan, RepliCel prioritizes focus on commercial revenue VANCOUVER, March 5, 2019 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.